Skip to main content

Leuprolide Acetate Use Among Patients with Central Precocious Puberty

    Basic Details
    Date Posted
    Medical Product
    leuprolide acetate
    Health Outcome(s)
    central precocious puberty

    The goal of this request was to characterize central precocious puberty (CPP) diagnoses and leuprolide acetate dispensing in the Sentinel Distributed Database (SDD). This request contains two reports. Report 1 examines the distribution of time between patients' first new diagnosis and leuprolide acetate dispensing. Report 2 contains counts of individuals with well child visits in the SDD.

    Data from January 1, 2000 to October 31, 2017 from 17 Data Partners contributing to the SDD were included in this report. This request was distributed to Data Partners on March 29, 2018.

    Additional Details
    FDA Center
    Time Period
    January 1, 2000 - October 31, 2017
    Analysis Type
    Population / Cohort
    Individuals 18 years of age and younger
    Data Sources
    Sentinel Distributed Database (SDD)